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Supplemental Table 1. Mutation status for 209 Study 19 patients with tumor assay results. Each patient tumor has a tumor mutation 
classification (BRCA1/2 loss-of-function mutation of germline, somatic, or unknown origin; VUS; or non-mutant), mutation type, amino acid 
change, predicted germline or somatic status, and predicted zygosity of mutations, compared with germline assay test type (CRF, Myriad, both, 
or not tested) and assay result (mutant, non-mutant, VUS, not tested) 




















gBRCA1m Frameshift Q1756fs*74 Germline Homozygous 
    
CRF Mutant 
gBRCA1m Frameshift E23fs*17 Germline Homozygous 
    
CRF Mutant 
gBRCA1m Frameshift E23fs*17 Germline Homozygous 










homozygous     
Both Mutant 
gBRCA1m Frameshift Q1756fs*74 Germline Homozygous 
    
CRF Mutant 
gBRCA1m Nonsense E418* Germline Homozygous 
    
Myriad Mutant 
gBRCA1m Frameshift E23fs*17 Germline Homozygous 
    
CRF Mutant 
gBRCA1m Nonsense Y978* Germline Homozygous 
    
Both Mutant 
gBRCA1m Frameshift Q1756fs*74 Germline Homozygous 
    
Not tested Not tested 
gBRCA1m Frameshift S1655fs*16 Germline Homozygous 




Frameshift Q1756fs*74 Germline Homozygous VUS P1819S Germline Heterozygous Both Mutant 
gBRCA1m Frameshift T826fs*20 Germline Homozygous 
    
Both Mutant 
gBRCA1m Frameshift E23fs*17 Germline Homozygous 
    
Both Mutant 
gBRCA1m Frameshift Q1756fs*74 Germline Homozygous 
    
Not tested Not tested 
gBRCA1m Frameshift Q1756fs*74 Germline Homozygous 
    
Myriad Mutant 
gBRCA1m Frameshift E23fs*17 Germline Homozygous 
    
CRF Mutant 
gBRCA1m Frameshift E23fs*17 Germline Homozygous 
    
CRF Mutant 
gBRCA1m Nonsense R1203* Germline Homozygous 
    
Not tested Not tested 
gBRCA1m  
(+ VUS) 






not in tumor 
Both Mutant 
gBRCA1m Frameshift Q1756fs*74 Germline Homozygous 
    
Both Mutant 
gBRCA1m Nonsense R1203* Germline Homozygous 















Frameshift Q1756fs*74 Germline Homozygous VUS S1172L Germline Heterozygous Both Mutant 
gBRCA1m 
(+ VUS) 
Frameshift K654fs*47 Germline Homozygous VUS S384F Germline Heterozygous CRF Mutant 
gBRCA1m Nonsense Q74* Germline Homozygous 
    
Myriad Mutant 
gBRCA1m Frameshift P1238fs*26 Germline Homozygous 
    
Not tested Not tested 
gBRCA1m Frameshift E23fs*17 Germline Homozygous 
    
Both Mutant 
gBRCA1m Frameshift Q1756fs*74 Germline Homozygous 
    
Myriad Non-mutant 
gBRCA1m Nonsense E1250* Germline Homozygous 
    
Both Mutant 
gBRCA1m Frameshift V1234fs*8 Germline Homozygous 
    
Myriad Mutant 
gBRCA1m Frameshift S1253fs*10 Germline Homozygous 
    
Both Mutant 
gBRCA1m Frameshift A807fs*8 Germline Homozygous 
    
Both Mutant 
gBRCA1m Frameshift E23fs*17 Germline Homozygous 
















not in tumor; 
not in tumor 
    
CRF Mutant 
gBRCA1m Frameshift Q1756fs*74 Germline Homozygous 
    
Myriad Mutant 
gBRCA1m Frameshift Q1756fs*74 Germline Homozygous 











homozygous     










homozygous     
Myriad Mutant 
gBRCA1m Frameshift Q1756fs*74 Germline Homozygous 
    
Both Mutant 
gBRCA1m Frameshift D1065fs*2 Germline Homozygous 
    
Myriad Mutant 
gBRCA1m Nonsense R1203* Germline Homozygous 











homozygous     
Not tested Not tested 
gBRCA1m Frameshift E23fs*17 Germline Homozygous 
    
CRF Mutant 
gBRCA1m Frameshift Q1756fs*74 Germline Homozygous 
    
Not tested Not tested 
gBRCA1m Nonsense Q780* Germline Unknown 
    
Both Mutant 
gBRCA1m Frameshift S945fs*6 Germline Unknown 
    
Not tested Not tested 
gBRCA1m Frameshift R1835fs*10+ Germline Unknown 
    
Both Mutant 
gBRCA1m Frameshift E23fs*17 Germline Unknown 
    
CRF Mutant 
gBRCA1m Frameshift Q1756fs*74 Germline Unknown 
    
Myriad Mutant 
gBRCA1m Nonsense E908* Germline Unknown 
    
Both Mutant 
gBRCA1m Frameshift P1806fs*28 Germline Unknown 
    
Myriad Mutant 
gBRCA1m Frameshift M1083fs*1 Germline Unknown 
    
Myriad Mutant 
gBRCA1m Nonsense R1443* Germline Unknown 
    
CRF Mutant 
gBRCA1m Frameshift S1428fs*6 Germline Unknown 
    
Both Mutant 
gBRCA1m Frameshift Q1756fs*74 Germline Unknown 
    
Myriad Mutant 
gBRCA1m Frameshift Q1756fs*74 Germline Unknown 
    
Both Mutant 
sBRCA1m Nonsense R1203* Somatic Homozygous 
    
CRF Non-mutant 
sBRCA1m Frameshift I600fs*7 Somatic Homozygous 
    
Myriad Non-mutant 
sBRCA1m Frameshift S1486fs*19 Somatic Homozygous 
    
Myriad Non-mutant 
sBRCA1m Frameshift N542fs*2 Somatic Homozygous 
    
Myriad Non-mutant 
sBRCA1m Frameshift L1472fs*33 Somatic Homozygous 
    
Not tested Not tested 
sBRCA1m Frameshift K50fs*19 Somatic Homozygous 
    
Myriad Non-mutant 
sBRCA1m Nonsense E1629* Somatic Homozygous 
    
Myriad Non-mutant 
sBRCA1m Nonsense Q1327* Somatic Homozygous 
    
Myriad Non-mutant 
(s)BRCA1m Frameshift N1355fs*10 NA Unknown 
    
Myriad Non-mutant 
gBRCA1m Splice Splice Germline Homozygous 
    
Both Mutant 
sBRCA1m Splice Splice Somatic Homozygous 
    
Not tested Not tested 
sBRCA1m Splice Splice Somatic Homozygous 
    
Not tested Not tested 
(g)BRCA1m Deletion 0 copies 





R1699Q Germline Homozygous 










A1708E Germline Homozygous 





R1699W Germline Homozygous 





M1T Somatic Homozygous 















    
Frameshift A938fs*21 Germline Homozygous Myriad Non-mutant 
gBRCA2m 
    
Nonsense S1882* Germline Homozygous Myriad Mutant 
gBRCA2m 
    
Frameshift; V1610fs*4; Germline Homozygous; Not tested Not tested 
(+ VUS) VUS splice not in tumor 
gBRCA2m 
    
Frameshift L1466fs*2 Germline Homozygous Not tested Not tested 
gBRCA2m 
    
Frameshift E1493fs*10 Germline Homozygous Myriad Mutant 
gBRCA2m 
    
Frameshift S1982fs*22 Germline Homozygous CRF Mutant 
gBRCA2m 
    
Frameshift W1692fs*3 Germline Homozygous Both Mutant 
gBRCA2m 
    
Frameshift V1283fs*2 Germline Homozygous Myriad Mutant 
gBRCA2m 
    
Frameshift F2254fs*6 Germline Homozygous Not tested Not tested 
gBRCA2m 
(+ VUS) 
VUS L440S Germline Homozygous Nonsense R3128* Germline Homozygous Both Mutant 
gBRCA2m 
    
Frameshift V1610fs*4 Germline Homozygous CRF Non-mutant 
gBRCA2m 
    
Frameshift S1982fs*22 Germline Homozygous CRF Mutant 
gBRCA2m 








not in tumor 
Myriad Mutant 
gBRCA2m 
    
Frameshift Q2009fs*9 Germline Homozygous CRF Mutant 
gBRCA2m 
    
Frameshift N1544fs*4 Germline Homozygous Myriad Mutant 
gBRCA2m 




Germline Homozygous Myriad Mutant 
gBRCA2m 
    
Frameshift V1804fs*2 Germline Homozygous CRF Mutant 
gBRCA2m 
    
Frameshift Q1175fs*7 Germline Homozygous Not tested Not tested 
gBRCA2m 
    
Frameshift S1982fs*22 Germline Homozygous Both Mutant 
gBRCA2m 
    
Frameshift E1646fs*24 Germline Homozygous Myriad Mutant 
gBRCA2m 
    
Frameshift L2092fs*7 Germline Unknown Not tested Not tested 
gBRCA2m 
    
Frameshift S1982fs*22 Germline Unknown CRF Mutant 
gBRCA2m 
    
Frameshift E1646fs*24 Germline Unknown Both Mutant 
gBRCA2m 
    
Nonsense R2494* Germline Unknown Myriad Mutant 
gBRCA2m 
    
Frameshift R645fs*15 Germline Unknown CRF Mutant 
sBRCA2m 
    
Frameshift W31fs*1 Somatic Homozygous CRF Non-mutant 
sBRCA2m 








not in tumor 
Not tested Not tested 
sBRCA2m 
    
Frameshift D1321fs*14 Somatic Homozygous CRF Non-mutant 
sBRCA2m 
    
Frameshift D2005fs*34 Somatic Homozygous CRF Non-mutant 
sBRCA2m 
    
Frameshift L2996fs*5 Somatic Heterozygous CRF Non-mutant 
sBRCA2m 




Unknown Not tested Not tested 
sBRCA2m 
(+ VUS) 
VUS T826K Germline Homozygous Frameshift T2515fs*9 
Subclonal 
somatic 
Unknown Not tested Not tested 
(s)BRCA2m 
    




    




    
Deletion 0 copies 
  
Not tested Not tested 
(gBRCA; FM 
tumor no call) 
(Insertion) 
       
CRF Mutant 
(gBRCA; FM (Insertion) 
       
Myriad Mutant 
tumor no call) 
(gBRCA; FM 
tumor no call) 
(Deletion) 
       
CRF Mutant 
VUS-LOH VUS T1700I Germline Homozygous 
    
Myriad VUS 
VUS-LOH 
    
VUS N2113S Germline Homozygous CRF Non-mutant 
VUS-LOH 
    
VUS D2679Y Germline Homozygous Myriad VUS 
VUS-LOH VUS E649Q Germline Homozygous 
    
Myriad VUS 
VUS-LOH 
    
VUS K607T Germline Homozygous Not tested Not tested 
VUS-NA VUS Q804H Germline Unknown 
    
Myriad Non-mutant 
VUS-NA VUS R504C Germline Unknown 
    
Both Non-mutant 
VUS-NA  










    
VUS D125G Germline Heterozygous Not tested Not tested 
VUS-NIT 
    




Germline Not in tumor 
    
Myriad Non-mutant 
VUS-NIT VUS N799K Germline Not in tumor 
    
Myriad VUS 
Non-mutant 
(S236R SNP)     
Non-mutant 
VUS 
S326R Germline Not in tumor Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Both Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Both Non-mutant 
Non-mutant 
        
Both Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Not tested Not tested 
Non-mutant 
        
Not tested Not tested 
Non-mutant 
        
CRF Non-mutant 
Non-mutant 
        
CRF Non-mutant 
Non-mutant 
        
CRF Non-mutant 
Non-mutant 
        
Both Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Not tested Not tested 
Non-mutant 
        
Not tested Not tested 
Non-mutant 
        
Not tested Not tested 
Non-mutant 
        
Not tested Not tested 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Both Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Not tested Not tested 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Not tested Not tested 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Both Non-mutant 
Non-mutant 
        
Both Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Both Non-mutant 
Non-mutant 
        
Both Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Both Non-mutant 
Non-mutant 
        
CRF Non-mutant 
Non-mutant 
        
Not tested Not tested 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Not tested Not tested 
Non-mutant 
        
Myriad Bon-mutant 
Non-mutant 
        
Not tested Not tested 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Both Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Both Non-mutant 
Non-mutant 
        
Both Non-mutant 
Non-mutant 
        
Not tested Not tested 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Not tested Not tested 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
CRF Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Both Non-mutant 
Non-mutant 
        
Myriad Non-mutant 
Non-mutant 
        
Not tested Not tested 
Non-mutant 
        
Myriad Non-mutant 
CRF, case report form; FM, Foundation medicine; gBRCAm, germline BRCA mutation; HET, heterozygous; LOH, loss of heterozygosity; NA, not available; NIT, not in 
tumor; sBRCAm, somatic BRCA mutation; SNP, single nucleotide polymorphism; VUS, variant of unknown significance
Supplemental Table 2. Comparison of BRCA1/2 mutations for Study 19 with three 
published cohorts of high-grade serous ovarian cancer patients [1-3]. Number of patients 
sequenced, origin of BRCA1/2 mutation (germline, somatic, or unknown), frequencies of 
BRCA1/2 mutation, and somatic mutation rates are presented. Some data for Hennessey et al. 












209 249 316 158 
BRCA1/2m, n 114 65 63 36 
Germline 93 53 44a N/A 
Somatic 20 12 19 N/A 
Unknown 1 0 0 N/A 
BRCAm, % 55 26 20 23 
sBRCAm, % 18 18 30 39b 
aSubtracted three reported germline mutations (BRCA2 K3326X is a benign polymorphism); bRepresents 11 
somatic mutations in a subset of 28 BRCA1/2-mutated patients tested with no grade or histology stated. 
HG-SOC, high-grade serous ovarian cancer; N/A, not available; TCGA, The Cancer Genome Atlas 
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